Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Recent Articles in Archived Articles

The Day In Review: Biosite Takes $85 Offer From Beckman Coulter
Mar 26, 2007
CBT 200 Slips 4 Points Lower. More details...
The Week In Review: Biotech Recovers Some Lost Ground
Mar 25, 2007
CBT 200 Rises 95 Points. More details...
The Day In Review: A Perfect Storm for Genentech And Amgen
Mar 23, 2007
CBT 200 Falls 34 Points. More details...
Bad News From Amgen And Genentech
Mar 23, 2007
Decline In Two Biggest Biotechs Takes Toll On CBT 200 Index. More details...
The Day In Review: Eisai Buys Morphotek For $325 Million
Mar 22, 2007
CBT 200 Makes A Small Gain Of 8 Points. More details...
More Articles >>
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital